Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of March 13, 2025 • 5:31 PM ET

Date/Time Source News Release
02/24/2025 08:30 AM EST GlobeNewswire Vivos Therapeutics Expands Strategic Alliance in Colorado and Seeks New Sleep Center Affiliations and Acquisitions Nationwide
02/18/2025 08:30 AM EST GlobeNewswire Vivos Therapeutics to Participate in Fireside Chat with Water Tower Research on February 18, 2025 at 12:00 pm ET.
12/23/2024 08:00 AM EST GlobeNewswire Vivos Therapeutics Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
11/14/2024 04:05 PM EST GlobeNewswire Vivos Therapeutics Reports Third Quarter 2024 Financial Results and Provides Operational Update
11/13/2024 05:00 PM EST GlobeNewswire Vivos Therapeutics Schedules Release of Third Quarter 2024 Financial Results and Conference Call
10/08/2024 07:30 AM EDT GlobeNewswire Vivos Therapeutics Granted CPT® Coverage and Reimbursement Codes for All Vivos CARE Oral Medical Devices From American Medical Association
09/19/2024 07:00 AM EDT GlobeNewswire Vivos Therapeutics Announces Pricing of $4.3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
09/18/2024 07:00 AM EDT GlobeNewswire Vivos Therapeutics Receives Groundbreaking FDA 510(k) Clearance to Treat Moderate to Severe Pediatric Sleep Apnea and Snoring
08/14/2024 04:05 PM EDT GlobeNewswire Vivos Therapeutics Reports Second Quarter 2024 Financial Results and Provides Operational Update
08/14/2024 07:30 AM EDT GlobeNewswire Vivos Therapeutics Schedules Release of Second Quarter 2024 Financial Results and Conference Call
Page

Additional News

As of March 13, 2025 • 5:31 PM ET

Date/Time Source News Release
02/28/2025 07:15 AM EST Zacks Amneal Pharmaceuticals (AMRX) Q4 Earnings Lag Estimates
02/11/2025 04:40 PM EST SeekingAlpha Vivos Therapeutics announces up to $50M mixed shelf offering
01/22/2025 07:56 AM EST SeekingAlpha Vivos Therapeutics announces sale of up to 854,332 shares by selling stockholders
01/08/2025 10:15 AM EST Zacks Best Momentum Stocks to Buy for January 8th
01/08/2025 07:07 AM EST Zacks New Strong Buy Stocks for January 8th
12/18/2024 12:00 PM EST Zacks All You Need to Know About Vivos Therapeutics (VVOS) Rating Upgrade to Buy
11/27/2024 04:31 AM EST US Earnings Reports Expected earnings - Vivos Therapeutics Inc.
11/15/2024 10:02 AM EST SeekingAlpha Vivos Therapeutics GAAP EPS of -$0.40, revenue of $3.86M
11/07/2024 05:35 PM EST Zacks Collegium Pharmaceutical (COLL) Q3 Earnings and Revenues Lag Estimates
10/08/2024 08:30 AM EDT InvestorBrandNetwork InvestorNewsBreaks - Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces AMA Issues CPT Codes, Coverage for Vivos CARE Oral Medical Devices
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.